The B share capital of the following share will be reduced on NASDAQ OMX
Copenhagen with effect from 25 April 2012.
On a general meeting in Novo Nordisk it was adopted to reduce the share capital by cancelling own B - shares.
ISIN DK0060102614 ----------------------------------------------------------- Name: Novo Nordisk B ----------------------------------------------------------- Volume before change: 472,512,800 shares (DKK 472,512,800) ----------------------------------------------------------- Change: 20,000,000 shares (DKK 20,000,000) ----------------------------------------------------------- Volume after change: 452,512,800 shares (DKK 452,512,800) ----------------------------------------------------------- Face value: DKK 1 ----------------------------------------------------------- Short name: NOVO B ----------------------------------------------------------- Orderbook ID: 1158 -----------------------------------------------------------
For further information, please contact: Helene Gaustad Jeppesen, Surveillance, tel. +45 33 93 33 66
Attachment:
https://newsclient.omxgroup.com/cds/DisclosureAttachmentServlet?messageAttachmentId=388705
On a general meeting in Novo Nordisk it was adopted to reduce the share capital by cancelling own B - shares.
ISIN DK0060102614 ----------------------------------------------------------- Name: Novo Nordisk B ----------------------------------------------------------- Volume before change: 472,512,800 shares (DKK 472,512,800) ----------------------------------------------------------- Change: 20,000,000 shares (DKK 20,000,000) ----------------------------------------------------------- Volume after change: 452,512,800 shares (DKK 452,512,800) ----------------------------------------------------------- Face value: DKK 1 ----------------------------------------------------------- Short name: NOVO B ----------------------------------------------------------- Orderbook ID: 1158 -----------------------------------------------------------
For further information, please contact: Helene Gaustad Jeppesen, Surveillance, tel. +45 33 93 33 66
Attachment:
https://newsclient.omxgroup.com/cds/DisclosureAttachmentServlet?messageAttachmentId=388705